All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Vaccitech Ltd., of Oxford, U.K., was launched with £10 million (US$14.4 million) in seed investment from Oxford Sciences Innovation to develop a universal flu vaccine for individuals older than 65.